Avantax Planning Partners, Inc. - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 74 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Avantax Planning Partners, Inc. ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$121,618
-43.6%
32,1740.0%0.01%
-44.4%
Q2 2023$215,566
+2.9%
32,1740.0%0.01%0.0%
Q1 2023$209,453
-23.7%
32,1740.0%0.01%
-18.2%
Q4 2022$274,444
+61.4%
32,1740.0%0.01%
+37.5%
Q3 2022$170,000
+25.0%
32,1740.0%0.01%
+33.3%
Q2 2022$136,000
+20.4%
32,1740.0%0.01%
+50.0%
Q1 2022$113,00032,1740.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 4,012,903$15,168,7737.77%
Nextech Invest Ltd. 1,910,029$7,219,9102.19%
K2 PRINCIPAL FUND, L.P. 2,552,062$9,646,7942.02%
Charles Schwab Trust Co 4,246,071$16,050,1481.81%
Sio Capital Management, LLC 1,105,911$4,180,3441.29%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$41,874,5640.92%
SECTORAL ASSET MANAGEMENT INC 1,049,191$3,965,9420.77%
Orbimed Advisors 9,240,887$34,930,5530.74%
RA Capital Management 9,459,678$35,757,5830.70%
K2 PRINCIPAL FUND, L.P. 688,900$2,604,0420.55%
View complete list of SILVERBACK THERAPEUTICS INC shareholders